Moreover, since autophagy has been shown to participate in tyrosine kinase inhibitor (TKI) resistance, a combination of TKI and autophagy inhibitor could also improve treatment, for example, in FLT3-ITD AML. This evidence concerns the gene FLT3 and acute myeloid leukemia.